By InvitationNot Applicable

Study on the Clinical Outcomes of ABO-Incompatible Living Donor Liver Transplantation

100 participantsStarted 2014-01-01

Plain-language summary

Evaluate the postoperative survival rate and incidence of rejection in patients undergoing ABO-incompatible living donor liver transplantation; analyze the occurrence of secondary endpoint events such as postoperative vascular complications and biliary complications; and explore relevant risk factors affecting prognosis.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Underwent ABO-incompatible living donor liver transplantation
✓. Complete and intact clinical and follow-up data

Exclusion criteria

✕. Non-primary liver transplantation
✕. Combined other organ transplantation
✕. Incomplete clinical data or loss to follow-up

What they're measuring

Postoperative survival rate

Timeframe: Minimum follow-up period of 1 year postoperatively.

incidence of acute rejection

Timeframe: Within 1 year postoperatively

Trial details

NCT IDNCT07273448

SponsorRu-zhou Cai

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2028-12-31

View on ClinicalTrials.gov More ABO Incompatibility trials